β¬300 million for Iberian BioTech and DeepTech as CriteriaCaixa rebrands its VC arm
CriteriaCaixa rebrands its VC arm, investing β¬300 million in Iberian BioTech and DeepTech firms. The funds will prioritize Spain and Portugal, selectively expanding to Europe and North America.
EU-Startups
Read more 13 jul 2026
